Natural coumarins: exploring the pharmacological complexity and underlying molecular mechanisms
J Sharifi-Rad, N Cruz-Martins… - Oxidative Medicine …, 2021 - Wiley Online Library
Coumarins belong to the benzopyrone family commonly found in many medicinal plants.
Natural coumarins demonstrated a wide spectrum of pharmacological activities, including …
Natural coumarins demonstrated a wide spectrum of pharmacological activities, including …
[HTML][HTML] The hypercoagulable state of malignancy: pathogenesis and current debate
GJ Caine, PS Stonelake, GYH Lip… - Neoplasia (New York …, 2002 - ncbi.nlm.nih.gov
A hypercoagulable or prothrombotic state of malignancy occurs due to the ability of tumor
cells to activate the coagulation system. It has been estimated that hypercoagulation …
cells to activate the coagulation system. It has been estimated that hypercoagulation …
Prognosis of cancers associated with venous thromboembolism
HT Sørensen, L Mellemkjær, JH Olsen… - New England Journal …, 2000 - Mass Medical Soc
Background Little is known about the prognosis of cancer discovered during or after an
episode of venous thromboembolism. Methods We linked the Danish National Registry of …
episode of venous thromboembolism. Methods We linked the Danish National Registry of …
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
M Di Nisio, E Porreca, M Candeloro… - Cochrane Database …, 2016 - cochranelibrary.com
Background Venous thromboembolism (VTE) often complicates the clinical course of
cancer. The risk is further increased by chemotherapy, but the trade‐off between safety and …
cancer. The risk is further increased by chemotherapy, but the trade‐off between safety and …
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
M Levine, J Hirsh, A Arnold, M Gent, V Bramwell… - The Lancet, 1994 - Elsevier
Patients receiving chemotherapy for metastatic breast cancer are at high risk of
thromboembolic disease. Long-term oral anticoagulant therapy is needed but increases the …
thromboembolic disease. Long-term oral anticoagulant therapy is needed but increases the …
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
AYY Lee, FR Rickles, JA Julian, M Gent… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Experimental studies and indirect clinical evidence suggest that low molecular
weight heparins may have antineoplastic effects. We investigated the influence of a low …
weight heparins may have antineoplastic effects. We investigated the influence of a low …
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism
S Schulman, P Lindmarker - New England Journal of Medicine, 2000 - Mass Medical Soc
Background The length of time after an episode of venous thromboembolism during which
the risk of newly diagnosed cancer is increased is not known, and whether vitamin K …
the risk of newly diagnosed cancer is increased is not known, and whether vitamin K …
Fibrin as a component of the tumor stroma: origins and biological significance
HF Dvorak, DR Senger, AM Dvorak - Cancer and Metastasis Reviews, 1983 - Springer
An association between cancer and the coagulation system was suggested by Trousseau
more than a century ago and initial reports of fibrin deposition in the stroma of solid tumors …
more than a century ago and initial reports of fibrin deposition in the stroma of solid tumors …
Inhibition of metastases by anticoagulants
M Hejna, M Raderer, CC Zielinski - Journal of the national …, 1999 - academic.oup.com
Metastasis involves several distinct steps, including one in which the tumor cell, after entry
into the bloodstream, comes to rest in a capillary located at the distant site where a …
into the bloodstream, comes to rest in a capillary located at the distant site where a …
A meta‐analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications
NM Kuderer, AA Khorana, GH Lyman, CW Francis - Cancer, 2007 - Wiley Online Library
BACKGROUND. Preclinical evidence suggests that anticoagulants, in particular the low‐
molecular‐weight heparins (LMWH), exert an antitumor effect, whereas clinical trials have …
molecular‐weight heparins (LMWH), exert an antitumor effect, whereas clinical trials have …